Digestive & Intestinal Remedies Market Worth $22.9 Billion By 2028

 

The global Digestive & Intestinal Remedies Market size is expected to reach USD 22.9 billion by 2028, registering a CAGR of 3.5% from 2022 to 2028, according to a new report by Grand View Research, Inc. Digestive medicines are the most common over the counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues such as acidity and other digestive problems. But in several countries, these medicines are sold directly to the patients without prescription as per their rules and regulations.

The market is majorly driven by high demand for over-the-counter products such as zientac, omez, and others. There is an increase in gastrointestinal disorders cases among people. Moreover, increasing cases of inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness are other factors that in turn are boosting market growth over the forecast period.

The market growth is driven by the developments and expansion of fast-food joints and the food service industry. Due to the expansion of hotels, restaurants, and junk food places across the world, consumption of oily, spicy, and unhygienic food has increased extremely. Moreover, increasing disposable income and a hectic lifestyle are facilitating the trend of eating out. This significantly leads to digestive and intestinal problems such as acidity, upset stomach, inflammations, etc., and increases consumption of digestive and intestinal remedies.

During the COVID-19 pandemic, the sales of digestive and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports which showed that a decrease in digestive and intestinal remedies has affected their bottom line sales in the market.

The digestive medicines accounted for the largest revenue share of over 50% in 2021 owing to the increasing demand for these drugs due to rising health issues. The rising aging population is also another key factor driving the segment growth. Moreover, altering lifestyles and diets has also increased the demand for digestive remedies products. Hence, owing to these reasons the segment is estimated to show growth over the estimated period.

The offline segment dominated the market with the highest share of over 70% in 2021. The demand for digestives & intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence the segment is projected to show growth during the assessment period.

North America dominated the market and accounted for around 45% revenue share in 2021 due to the growing number of gastrointestinal diseases in this region. Also, the growing geriatric and obese population in this region is driving the market growth. Increasing research and development activities along with the presence of key market players are other factors boosting market growth over the forecast period.

Related Press Release@ Digestive & Intestinal Remedies Market Report

List of Key Players in Digestive & Intestinal Remedies Market

• Bayer Healthcare
• Johnson & Johnson
• GlaxoSmithKline Plc
• Procter & Gamble Co
• Sanofi
• Boehringer Ingelheim GmbH
• Reckitt Benckiser Group Plc (RB)
• Abbott Laboratories Inc.
• Takeda Pharmaceutical Co Ltd
• Menarini Group

Digestive & Intestinal Remedies Market Report Highlights

• Asia Pacific is expected to register the fastest CAGR of 4.1% from 2022 to 2028 owing to rising demand for digestives & intestinal remedies due to the increasing prevalence of GI illness disease
• The digestive medicines accounted for the largest revenue share of over 50% in 2021 owing to the increasing demand for these drugs due to rising health issues
• The offline segment dominated the market with the highest share of 70% in 2021 owing to its increasing sales
• The remedies against gastrointestinal complaints segment will register the highest growth at 3.7% from 2022 to 2028 due to its growing cases of gastrointestinal disease 

Digestive & Intestinal Remedies Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 18.5 billion
Revenue forecast in 2028	USD 22.9 billion
Growth Rate	CAGR of 3.5% from 2022 to 2028
Base year for estimation	2021
Historical data	2017 - 2020
Forecast period	2022 - 2028

 

Related Reports@

Digestive Enzyme Supplements Market

Digestive Health Supplements Market

Digestive & Intestinal Remedies Market Segmentation

Grand View Research has segmented the global digestive & intestinal remedies market based on type, distribution channel, and region: 

Digestives & Intestinal Remedies Type Outlook (Revenue, USD Million, 2017 - 2028)

• Digestive Medicines
• Remedies Against Gastrointestinal Complaints
• Natural And Synthetic Agents

Digestives & Intestinal Remedies Distribution channel Outlook (Revenue, USD Million, 2017 - 2028)

• Online
• Offline

Digestives & Intestinal Remedies Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
• U.S.
• Europe
• Germany
• U.K.
• France
• Asia Pacific
• China
• Japan
• Central & South America
• Brazil
• Middle East & Africa
• South Africa 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Active Wound Care Market Size Worth $2.2 Billion By 2030

 

The global Active Wound Care Market size is anticipated to reach USD 2.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2022 to 2030. The increasing prevalence of chronic and acute wounds, rapidly aging population, rising number of diabetic patients,, and surge in research and development activities are the major factors driving the market. 

The rising demand for skin grafts is a primary driver of market expansion. Burn care and treatment have recently changed to a more holistic strategy that focuses not only on healing from burn injury but also on enhancement in long-term function and shape of the healed lesion, as well as the quality of life. As a result of this trend, the need for grafting and other substitutes in the treatment and management of acute burns has increased and continues to rise. 

Skin grafts are commonly utilized on partial and full-thickness burns and play a significant role in burn injury treatment. Furthermore, these grafts give a more intact extracellular matrix, which benefits wound healing. Because of the existence of a foundation membrane, skin grafts allow for efficient re-epithelization and provide greater control over scaffold composition. In terms of absorbency and frequency of dressing change, it also outperforms other dressing materials. The aforementioned benefits are expected to fuel the market's overall expansion. 

Furthermore, there are several growth factors known to impose significant effects on surgical use, including PDGF, VEGF, FGF, epidermal growth factor (EGF), keratinocyte growth factor (KGF), transforming growth factor-beta (TGF-), granulocyte-macrophage colony-stimulating factor (GM-CSF), and others, due to advancements in genetic engineering and biological technology. Growth factors attract cells into wounds, boost their proliferation, and have a great impact on extracellular matrix deposition. It has led to statistically significant improvements in tissue repair. Such factors are contributing to market growth. 

Related Press Release@ Active Wound Care Market Report

List of Key Players of the Active Wound Care Market

• Smith & Nephew
• MiMedx
• Tissue Regenix
• Organogenesis Inc.
• Acell Inc.
• Integra Life Sciences
• Solsys Medical
• Osiris Therapeutics Inc.
• Cytori Therapeutics Inc.
• Human BioSciences
• Wright Medical Group N.V

Active Wound Care Market Report Highlights

• Based on product, the biomaterials segment dominated the market and accounted for a revenue share of 44.4% in 2021, owing to an increase in research and development and the launch of novel products
• Based on application, the chronic wound segment is likely to witness the fastest growth over the forecast period, owing to an increase in the number of diabetic foot ulcers and pressure ulcers
• Based on end-use, the hospital segment dominated the market, owing to the increasing number of admissions for wound injuries and the developing healthcare infrastructure
• North America dominated the market with the highest revenue share of more than 59.0% in 2021 owing to the large presence of key players and rising adoption of advanced active wound care products 

Active Wound Care Market Report Scope 

Report Attribute	Details
Market size value in 2022	USD 1,536.8 million
Revenue forecast in 2030	USD 2.2 billion
Growth rate	CAGR of 4.7% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030

 

Related Reports@

Wound Care Market

Advanced Wound Care Market

Active Wound Care Market Segmentation 

Grand View Research has segmented the global active wound care market based on product, application, end-use, and region:

Active Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Biomaterials
• Skin-substitutes

• Biological Skin-substitute

• Allograft
• Xenograft
• Others
• Synthetic Skin-substitute
• Growth Factors

Active Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Wounds

• Diabetic foot ulcers
• Pressure ulcers
• Venous leg ulcers
• Other chronic wounds
• Acute Wounds
• Surgical & traumatic wounds
• Burns

Active Wound Care End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Active Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Brazil
• Argentina
• Mexico
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Irradiation Sterilization Services Market by STERIS; Röchling Group; Sterigenics; Scapa Healthcare; Swann-Morton; SteriTek; Beta-Gamma-Service

 

The global Irradiation Sterilization Services Market size is expected to reach USD 4.59 billion by 2030, expanding at 10.53% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc.Irradiation sterilization is a process that uses ionizing radiation to eliminate microorganisms, including bacteria, viruses, fungi, and other pathogens. This process is commonly used to sterilize medical devices, pharmaceuticals, and food products. The demand for irradiation sterilization services has increased in recent years due to the growing concerns over foodborne illnesses and hospital-acquired infections.

The market is expanding as a result of factors such as the rise in hospital-acquired infections, technological developments in the use of sterilization agents & equipment in industrial facilities, and rising awareness of cleanliness in all institutions. On January 30, 2020, the World Health Organization (WHO) proclaimed the COVID-19 outbreak as an emergency of global significance in the public health domain. A total of 210 countries have been impacted by COVID-19. In healthcare settings, the equipment sterilization process has been essential for preventing the spread of COVID-19 infection.

By effectively sterilizing medical equipment, patient-to-patient pathogen transmission can be fully avoided. During the COVID-19 pandemic, more reprocessed equipment was used to sterilize or disinfect medical devices than usual, because improper decontamination of endoscopic, surgical, and reusable hemodialysis equipment could increase the probability of COVID-19 infection. To ensure proper sterilization of medical devices, there has been an increased demand for sterilization services. Therefore, the COVID-19 pandemic has positively impacted the growth of the global market.

The medical devices segment holds the largest share of the market for irradiation sterilization services. This is attributed to the increasing use of sterilized medical devices in surgeries and the rising number of hospitals and clinics. The food segment is also expected to grow at a significant rate due to the increasing demand for shelf-stable food products and the need to extend the shelf life of these items.

North America holds the largest share of the global market for irradiation sterilization services due to the presence of several medical device manufacturers and the growing demand for sterilized medical devices and food products in the region. The Asia-Pacific region is expected to expand at the highest rate during the forecast period due to the increasing number of hospitals and clinics in the region and the rising demand for sterilized food products and medical devices.

The various key players in the irradiation sterilization services industry offer a wide range of solutions to meet the sterilization needs of medical device manufacturers, pharmaceutical companies, and food producers. Companies utilize state-of-the-art technologies and adhere to strict quality control measures to ensure the highest levels of safety and efficacy.

Related Press Release@ Irradiation Sterilization Services Market Report

List of Key Players in the Irradiation Sterilization Services Market

• STERIS
• Röchling Group
• Sterigenics
• Scapa Healthcare
• Swann-Morton
• SteriTek
• Beta-Gamma-Service
• Taisei Kako
• China Biotech Corporation
• Ionisos
• E-BEAM Services

Irradiation Sterilization Services Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 2.28 billion
Revenue forecast in 2030	USD 4.59 billion
Growth rate	CAGR of 10.53% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

 

Related Reports@

Surgical Equipment Market

Sterilization Equipment Market

Irradiation Sterilization Services Market Report Highlights

• By application, the medical instruments segment accounted for the largest share in 2022. A rise in the geriatric population, and an increase in government awareness campaigns to assure high levels of infection prevention, are factors propelling the market growth
• By product type, the gamma irradiation segment accounted for the largest share in 2022. The market is expanding as a result of the high penetrating capability of gamma irradiation. which is expected to propel segment growth
• North America held the highest share of the global market in 2022. This is mostly due to the presence of major market participants in the region, as well as increased R&D spending and government support
• The Asia Pacific region is expected to advance at the highest rate during the forecast period. This is attributed to the rising prevalence of HAI diseases among the aging population and the growing adoption of irradiation sterilization services, among other factors

Irradiation Sterilization Services Market Segmentation

Grand View Research has segmented the global irradiation sterilization services market based on application, product type, and region:

Irradiation Sterilization Services Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Medical Instruments
• Drug
• Food & Laboratory
• Others

Irradiation Sterilization Services Product Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Gamma Irradiation
• X-ray Irradiation
• E-beam Irradiation

Irradiation Sterilization Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com